1. Home
  2. ABEO vs JRVR Comparison

ABEO vs JRVR Comparison

Compare ABEO & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$2.42

Market Cap

282.5M

Sector

Health Care

ML Signal

N/A

Logo James River Group Holdings Ltd.

JRVR

James River Group Holdings Ltd.

HOLD

Current Price

$2.89

Market Cap

209.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEO
JRVR
Founded
1974
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
282.5M
209.9M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
ABEO
JRVR
Price
$2.42
$2.89
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
★ $15.56
$3.73
AVG Volume (30 Days)
★ 2.2M
386.4K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
★ 1.37%
EPS Growth
★ 165.16
125.82
EPS
★ N/A
N/A
Revenue
$2,998,000.00
★ $687,614,000.00
Revenue This Year
$675.42
N/A
Revenue Next Year
$126.99
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 258.18
N/A
52 Week Low
$2.09
$2.90
52 Week High
$7.65
$7.20

Technical Indicators

Market Signals
Indicator
ABEO
JRVR
Relative Strength Index (RSI) 27.49 25.14
Support Level $2.09 N/A
Resistance Level $5.77 $4.16
Average True Range (ATR) 0.32 0.16
MACD -0.03 -0.08
Stochastic Oscillator 15.88 1.69

Price Performance

Historical Comparison
ABEO
JRVR

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.

Share on Social Networks: